Local micromobility start-ups want Mayor Mamdani to take their industry seriously and make it easier to ride an e-bike in NYC ...

Even in Marin, where local safety and education programs – for young riders and maybe more important their parents – have ...

Everyone has a view on what's wrong with the country, but I believe the main issues that make life worse for ordinary ...

Here at Cyclingnews, we've tested all the best bike computers from the leading brands, so we can give you unbiased advice on ...

At the December 16 Coronado City Council meeting, the City Manager, Tina Friend, introduced Coronado’s new Deputy City ...

Shares of Axsome Therapeutics AXSM were up 22.8% on Dec. 31, after it announced that the FDA had accepted the supplemental new drug application (“sNDA”) seeking approval for AXS-05 (dextromethorphan ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press ...

NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

Despite several indicators that Rad Power Bikes could be heading for closure soon, the brand announced the launch of ...

NEW YORK - The U.S. Food and Drug Administration has accepted Axsome Therapeutics’ (NASDAQ:AXSM) supplemental New Drug Application for AXS-05 to treat Alzheimer’s disease agitation and granted it ...

FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (AXSM), a biopharmaceutical ...